as 07-26-2024 4:00pm EST
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Founded: | 1910 | Country: | United States |
Employees: | N/A | City: | IRVING |
Market Cap: | 47.5B | IPO Year: | N/A |
Target Price: | $145.35 | AVG Volume (30 days): | 2.3M |
Analyst Decision: | Hold | Number of Analysts: | 17 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 6.76 | EPS Growth: | 39.38 |
52 Week Low/High: | $116.32 - $145.62 | Next Earning Date: | 07-23-2024 |
Revenue: | $20,280,000,000 | Revenue Growth: | -0.32% |
Revenue Growth (this year): | 0.92% | Revenue Growth (next year): | 1.65% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Hsu Michael D. | KMB | Chairman of the Board and CEO | May 6 '24 | Sell | $136.06 | 3,387 | $460,842.67 | 229,863 | SEC Form 4 |
Hsu Michael D. | KMB | Chairman of the Board and CEO | May 6 '24 | Sell | $135.35 | 50,804 | $6,876,412.85 | 179,059 | SEC Form 4 |
Drexler Andrew | KMB | Vice President and Controller | May 1 '24 | Sell | $136.83 | 2,500 | $342,084.25 | 8,053 | SEC Form 4 |
Melucci Jeffrey P. | KMB | Chief Bus. & Transf. Officer | Apr 30 '24 | Sell | $135.53 | 13,714 | $1,858,621.39 | 19,935 | SEC Form 4 |
Chen Katy | KMB | President, APAC | Apr 29 '24 | Sell | $135.80 | 347 | $47,124.23 | 941 | SEC Form 4 |
Cunningham Doug | KMB | President, EMEA | Apr 29 '24 | Sell | $136.86 | 1,040 | $142,334.40 | 3,833 | SEC Form 4 |
Chen Katy | KMB | President, APAC | Apr 26 '24 | Sell | $135.24 | 189 | $25,560.36 | 785 | SEC Form 4 |
Chen Katy | KMB | President, APAC | Apr 26 '24 | Sell | $135.24 | 265 | $35,838.60 | 520 | SEC Form 4 |
Melucci Jeffrey P. | KMB | Chief Bus. & Transf. Officer | Apr 26 '24 | Sell | $135.59 | 6,390 | $866,443.74 | 33,649 | SEC Form 4 |
Fenske Tamera | KMB | Chief Supply Chain Officer | Apr 26 '24 | Sell | $135.37 | 717 | $97,057.57 | 2,284 | SEC Form 4 |
Uribe Gonzalo | KMB | President, Latin America | Apr 25 '24 | Sell | $136.91 | 1,465 | $200,573.74 | 8,679 | SEC Form 4 |
Karrmann Sandra R | KMB | Chief Human Resources Officer | Apr 24 '24 | Sell | $137.25 | 6,288 | $863,030.52 | 12,294 | SEC Form 4 |
Ramos Paula | KMB | Chief Strategy Officer | Apr 24 '24 | Sell | $137.17 | 10,178 | $1,396,097.94 | 795 | SEC Form 4 |
SMUCKER MARK T | KMB | Director | Jan 29 '24 | Buy | $120.98 | 388 | $46,940.24 | 388 | SEC Form 4 |
SMUCKER MARK T | KMB | Director | Jan 29 '24 | Buy | $120.99 | 239 | $28,916.61 | 627 | SEC Form 4 |
SMUCKER MARK T | KMB | Director | Jan 29 '24 | Buy | $120.97 | 200 | $24,194.00 | 827 | SEC Form 4 |
Wilkinson Tristram | KMB | President, APAC | Jan 26 '24 | Sell | $121.00 | 3,720 | $450,120.00 | 17,229 | SEC Form 4 |
Melucci Jeffrey P. | KMB | Chief Legal Officer | Nov 29 '23 | Sell | $121.71 | 3,000 | $365,130.00 | 25,169 | SEC Form 4 |
KMB Breaking Stock News: Dive into KMB Ticker-Specific Updates for Smart Investing
Zacks
11 hours ago
Argus Research
14 hours ago
Argus Research
14 hours ago
Zacks
a day ago
Simply Wall St.
2 days ago
MT Newswires
2 days ago
MT Newswires
2 days ago
MT Newswires
2 days ago
The information presented on this page, "KMB Kimberly-Clark Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.